ICMR Clinical begins trials on BCG Vaccine to treat COVID-19 infected patients

BCG Vaccine –

  • The Indian Council of Medical Research (ICMR) is going to carry a 10-month trial on the Bacillus Calmette-Guérin (BCG) vaccine. the trial will aim to make a vaccine that may help to prevent COVID-19 virus in human body.
  • BCG vaccine has been obtained from an isolate of Mycobacterium Bovis. Mycobacterium Bovis utilize a live attenuated strain where the pathogen’s potency is disabled artificially. this process is used in all parts of the world, India too. for last decades India uses it to treat tuberculosis (TB).

What is ICMR’s Trial:

  • ICMR is going to conduct a trial that aims on the vaccine’s potential to reduce the chance of COVID-19 patients deaths, in particular among those whose age are above 60.

About Indian Council of Medical Research (ICMR) –
Headquarters: New Delhi
Secretary & Director General: Dr. Balram Bhargava
Founder: Government of India
Founded: 1911

BCG vaccine

Q.1 What is the need of ICMR’s Trial?

ICMR’s Trial will aim to make a vaccine that may help to prevent COVID-19 virus in human body. Learn More

Q.2 what will be duration of ICMR’s Trial?

The Indian Council of Medical Research (ICMR) will carry a 10-month trial on the Bacillus Calmette-Guérin (BCG) vaccine. Learn More

Q.3 on which vaccine Indian Council of Medical Research (ICMR) will make trials?

Indian Council of Medical Research (ICMR) will make trials on Bacillus Calmette-Guérin (BCG) vaccine. Learn More

Q.4 Bacillus Calmette-Guérin (BCG) vaccine was derived from?

BCG (Bacillus Calmette-Guérin) vaccine has been obtained from an isolate of Mycobacterium Bovis. Learn More

About Yashhuu

ICMR Clinical begins trials on BCG Vaccine to treat COVID-19 infected patients 1I love To Write Articles, I Write articles in many fields technology, news, educations, exams, gadgets reviews, coding, Apps. Facebook

Leave a Comment